471 filings
Page 3 of 24
10-K
2022 FY
MYMD
MyMD Pharmaceuticals Inc
Annual report
31 Mar 23
5:01pm
8-K
MYMD
MyMD Pharmaceuticals Inc
23 Mar 23
Departure of Directors or Certain Officers
4:30pm
DEFA14A
MYMD
MyMD Pharmaceuticals Inc
22 Mar 23
Additional proxy soliciting materials
5:02pm
8-K
MYMD
MyMD Pharmaceuticals Inc
22 Mar 23
Other Events
5:00pm
8-K
MYMD
MyMD Pharmaceuticals Inc
20 Mar 23
MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis
9:15am
DEF 14A
MYMD
MyMD Pharmaceuticals Inc
Definitive proxy
13 Mar 23
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Mar 23
MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls
8:40am
PRE 14A
MYMD
MyMD Pharmaceuticals Inc
Preliminary proxy
3 Mar 23
5:10pm
8-K
MYMD
MyMD Pharmaceuticals Inc
2 Mar 23
MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines
8:45am
8-K
MYMD
MyMD Pharmaceuticals Inc
28 Feb 23
Regulation FD Disclosure
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
23 Feb 23
Entry into a Material Definitive Agreement
3:24pm
424B5
MYMD
MyMD Pharmaceuticals Inc
23 Feb 23
Prospectus supplement for primary offering
9:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
21 Feb 23
MyMD Announces $15 Million Offering with Existing Investors
9:00am
SC 13G/A
Iroquois Capital Management, LLC
14 Feb 23
MyMD Pharmaceuticals / Iroquois Capital Management ownership change
7:40am
8-K
MYMD
MyMD Pharmaceuticals Inc
3 Feb 23
Departure of Directors or Certain Officers
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
14 Dec 22
Submission of Matters to a Vote of Security Holders
5:00pm
4
Paul Rivard
8 Dec 22
MyMD Pharmaceuticals / Paul Rivard ownership change
8:24pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Dec 22
MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
18 Nov 22
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
14 Nov 22
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Data Research
8:32am